Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Indications: FDA : Resistant Hypertension 2025 Clinical Guidelines Reserpine remains an FDA-approved drug for the treatment of hypertension
Score your symptoms, get your metabolic scorecard, and find out which system to fix first.
PMID: 36 WuVSKanayaNLoCMortimerJChenS
The estimated half-life is 48 hours
Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
